Assignee
TRANSGENE SA
US·131 granted patents·23 pending applications·2,320 citations·filing 1987–2022
Top patents by PatentIndex Score
154 records- 0195US6040174ADefective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 1994·Granted Mar 21, 2000·212 cites·19 claims
- 0293US7670607B2Pharmaceutical compositions for treating papillomavirus tumors and infectionTRANSGENE SA·Filed 2008·Granted Mar 2, 2010·12 cites·21 claims
- 0393US7488482B2Pharmaceutical compositions for treating papillomavirus tumors and infectionTRANSGENE SA·Filed 2006·Granted Feb 10, 2009·24 cites·15 claims
- 0493US5112950AFactor viii analog, preparation process, and pharmaceutical composition containing itTRANSGENE SA·Filed 1991·Granted May 12, 1992·195 cites·6 claims
- 0592US7067310B2Method for the preparation of a viral vector by inter-molecular homologous recombinationTRANSGENE SA·Filed 2001·Granted Jun 27, 2006·40 cites·17 claims
- 0691US7572438B2Mutant having uracil phosphoribosyl transferase activityTRANSGENE SA·Filed 2005·Granted Aug 11, 2009·12 cites·7 claims
- 0790US6335199B1Lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic useTRANSGENE SA·Filed 1998·Granted Jan 1, 2002·110 cites·41 claims
- 0889US6350575B1Helper viruses for the preparation of recombinant viral vectorsTRANSGENE SA·Filed 2000·Granted Feb 26, 2002·25 cites·34 claims
- 0988US10555981B2Oncolytic virus for expression of immune checkpoint modulatorsTRANSGENE SA·Filed 2015·Granted Feb 11, 2020·9 cites·15 claims
- 1087US7118754B1Pharmaceutical composition for treating papillomavirus tumors and infectionTRANSGENE SA·Filed 2000·Granted Oct 10, 2006·22 cites·15 claims
- 1186US10190105B2HBV polymerase mutantsTRANSGENE SA·Filed 2016·Granted Jan 29, 2019·5 cites·40 claims
- 1286US6271208B1Process of making cationic lipid-nucleic acid complexesTRANSGENE SA·Filed 1997·Granted Aug 7, 2001·79 cites·35 claims
- 1386US6007806AExpression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumorTRANSGENE SA·Filed 1997·Granted Dec 28, 1999·77 cites·20 claims
- 1485US7148341B2AAV DNA comprising helper virus sequencesTRANSGENE SA·Filed 2001·Granted Dec 12, 2006·16 cites·15 claims
- 1584US6204060B1Viral vectors and line for gene therapyTRANSGENE SA·Filed 1996·Granted Mar 20, 2001·66 cites·42 claims
- 1684US6133028ADefective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 1999·Granted Oct 17, 2000·74 cites·33 claims
- 1784US6110735AMethod for the preparation of a viral vector by intermolecular homologous recombinationTRANSGENE SA·Filed 1995·Granted Aug 29, 2000·62 cites·18 claims
- 1883US5861381APharmaceutical composition for the treatment of a malignant tumorTRANSGENE SA·Filed 1995·Granted Jan 19, 1999·55 cites·13 claims
- 1983US5631144AApplication of novel DNA fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeast and corresponding process for the preparation of proteinsTRANSGENE SA·Filed 1995·Granted May 20, 1997·60 cites·25 claims
- 2082US11779619B2Oncolytic virus for expression of immune checkpoint modulatorsTRANSGENE SA·Filed 2019·Granted Oct 10, 2023·1 cites·21 claims
- 2182US9687515B2Poxviral oncolytic vectorsTRANSGENE SA·Filed 2014·Granted Jun 27, 2017·3 cites·14 claims
- 2282US9295702B2Process for producing poxviruses and poxvirus compositionsTRANSGENE SA·Filed 2014·Granted Mar 29, 2016·4 cites·19 claims
- 2382US6136594AReplication deficient recombinant adenovirus vectorTRANSGENE SA·Filed 1995·Granted Oct 24, 2000·34 cites·15 claims
- 2481US7264958B1Method for obtaining a purified viral preparationTRANSGENE SA·Filed 2000·Granted Sep 4, 2007·18 cites·19 claims
- 2581US6906041B2Treatment of immune diseasesTRANSGENE SA·Filed 2001·Granted Jun 14, 2005·19 cites·9 claims
- 2681US6884786B1Antitumoral composition based on immunogenic polypeptide with modified cell locationTRANSGENE SA·Filed 1998·Granted Apr 26, 2005·46 cites·34 claims
- 2781US6291423B1Lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapyTRANSGENE SA·Filed 1998·Granted Sep 18, 2001·30 cites·7 claims
- 2881US6281000B1Method for the preparation of a viral vector by intermolecular homologous recombinationTRANSGENE SA·Filed 1999·Granted Aug 28, 2001·45 cites·1 claims
- 2980US6740511B1Modified adenoviral fibre and uses thereofTRANSGENE SA·Filed 2000·Granted May 25, 2004·10 cites·5 claims
- 3080US5795577AViral vector coding for a glycoprotein of the virus responsible for A.I.D.S.TRANSGENE SA·Filed 1995·Granted Aug 18, 1998·46 cites·55 claims
- 3179US9139652B2Method for increasing M1 macrophages in a patientTRANSGENE SA·Filed 2012·Granted Sep 22, 2015·8 cites·14 claims
- 3279US7695960B2Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic useTRANSGENE SA·Filed 2007·Granted Apr 13, 2010·7 cites·32 claims
- 3378US7393831B2Peptide compositions and their use against HCVTRANSGENE SA·Filed 2003·Granted Jul 1, 2008·10 cites·12 claims
- 3477US9982055B2Antibody against the CSF-1RTRANSGENE SA·Filed 2016·Granted May 29, 2018·2 cites·18 claims
- 3576US7947288B2Viral particles encoding multifunctional cytokinesTRANSGENE SA·Filed 2009·Granted May 24, 2011·3 cites·16 claims
- 3676US6569677B1Modified adenoviral fiber and target adenovirusesTRANSGENE SA·Filed 1998·Granted May 27, 2003·34 cites·10 claims
- 3775US7378265B2Method of inactivating enveloped viruses in a viral preparation of non-enveloped virusesTRANSGENE SA·Filed 2005·Granted May 27, 2008·1 cites·29 claims
- 3874US9428584B2Antibody against the CSF-1RTRANSGENE SA·Filed 2013·Granted Aug 30, 2016·2 cites·18 claims
- 3974US7892828B2Method of identifying a MHC class I restricted T cell responseTRANSGENE SA·Filed 2009·Granted Feb 22, 2011·3 cites·3 claims
- 4074US7067309B2Defective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 2000·Granted Jun 27, 2006·2 cites·4 claims
- 4174US7005277B2Defective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 2000·Granted Feb 28, 2006·2 cites·8 claims
- 4274US6258791B1Combination product for enhanced gene delivery comprising a hyaluronidaseTRANSGENE SA·Filed 1998·Granted Jul 10, 2001·43 cites·13 claims
- 4374US5744133AExpression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumorTRANSGENE SA·Filed 1994·Granted Apr 28, 1998·48 cites·26 claims
- 4473US9221912B2Antibody against the CSF-1RTRANSGENE SA·Filed 2013·Granted Dec 29, 2015·2 cites·19 claims
- 4573US8357531B2Immortalized avian cell linesTRANSGENE SA·Filed 2010·Granted Jan 22, 2013·1 cites·6 claims
- 4672US6960469B2Adenoviral vectors encoding an antibody fused to a CD4 extracellular domainTRANSGENE SA·Filed 2001·Granted Nov 1, 2005·2 cites·10 claims
- 4772US6596533B1Mutant having uracil phosphoribosyl transferase activityTRANSGENE SA·Filed 1999·Granted Jul 22, 2003·23 cites·12 claims
- 4872US6514756B1Human myoblast cell lines and their usesTRANSGENE SA·Filed 2000·Granted Feb 4, 2003·4 cites·6 claims
- 4971US7608267B2Multifunctional cytokinesTRANSGENE SA·Filed 2004·Granted Oct 27, 2009·6 cites·25 claims
- 5071US7049117B2Mutant possessing uracil phosphoribosyl transferase activityTRANSGENE SA·Filed 2003·Granted May 23, 2006·4 cites·9 claims
Showing the top 50 of 154 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when TRANSGENE SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →